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Abstract
Castleman disease (CD) is a rare atypical lymphoprolifera-
tive process of obscure pathogenesis. An intracranial locali -
zation of the condition is extremely rare. We present a case of
a 29-year-old man, who harbored an intracranial plasma cell
variant of CD in the form of a tumor mimicking meningioma
and was followed up to 10 years after surgical excision of the
lesion. The histopathological examination showed massive
infiltration of mononuclear cells, composed mainly of lym-
phocytes and matured plasmocytes, as well as many small
thin-walled vessels surrounded with plasma cells and lym-
phocytes. This picture was consistent with a plasma cell type
of CD. Ten-year follow-up supports a notion that total sur-
gical excision of the solitary intracranial infiltration is cura-
tive in plasma cell type of CD.
Key words: Castleman disease, meningioma-like lesion, sur-
gical treatment.
A case of a solitary form of Castleman disease: ten-year follow-up
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CASE REPORT/OPIS PRZYPADKU
St reszc zen ie
Choroba Castlemana jest rzadkim, atypowym procesem lim-
foproliferacyjnym o niejasnej etiologii i patogenezie. Postaæ
o lokalizacji wewn¹trzczaszkowej rozpoznaje siê nadzwyczaj
rzadko. W pracy zaprezentowano przypadek 29-letniego mê¿ -
czyzny, u którego przedoperacyjnie stwierdzono zmianê „opo-
niakopodobn¹”, jednak badanie histopatologiczne ujawni³o
wewn¹trzczaszkow¹ postaæ choroby Castlemana o typie pla-
zmatycznokomórkowym. Chorego obserwowano przez 10 lat
po usuniêciu guza. W badaniu histopatologicznym stwier-
dzono naciek zapalny z³o¿ony g³ównie z limfocytów oraz doj-
rza³ych plazmocytów, a tak¿e liczne cienkoœcienne naczynia
otoczone komórkami plazmatycznymi i limfocytami. Obraz
histopatologiczny jednoznacznie wskazywa³ na postaæ pla-
zmatycznokomórkow¹ choroby Castlemana. Dziesiêcioletnia
obserwacja po usuniêciu zmiany wskazuje, ¿e ca³kowite wy-
ciêcie guza mo¿e zapewniæ trwa³y efekt leczniczy.
S³owa kluczowe: choroba Castlemana, zmiana oponiakopo-
dobna, leczenie operacyjne.
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Introduction
Castleman disease (CD, also known as giant lymph
node hyperplasia) is a rare lymphoproliferative process
described for the first time in 1956 by Benjamin Castle-
man as a thymoma-like lesion localized mediastinally
[1]. Subsequent reports have described similar lesions
localized in the abdomen, neck, lung, and the axilla, both
in nodal and non-nodal tissues. Clinically, CD is classi-
fied as localized/solitary or multicentric [2,3]. There
are also two distinctive histological forms of CD: first,
a hyaline-vascular form, which occurs in 85-90% of
localized tumors; and second, a plasma cell form, which
affects 80-90% of patients with multicentric CD [2,3].
Castleman disease may invade the central nervous
system; however, this localization is extremely rare. Since
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its first description in 1983 by Lacombe et al., only a few
case reports have been published [4-10]. Intracranial
lesions were found to be solitary [5-9]; however, they
could also constitute part of a multicentric angiofollic-
ular lymphoid hyperplasia [10]. We present a patient
who was referred to us with a diagnosis of intracranial
meningioma, which eventually turned out to be a case
of localized intracranial CD. What makes our case uni -
que among other similar reports is the long period of
follow-up, which amounts to 10 years.
Case report
A 29-year-old man was treated in our department 
in 2003, admitted after two incidents of syncope, which
had occurred 6 months and 10 days before admission.
He was complaining of severe headache, which he had
suffered once to twice a week for the past 2 years. Before
that time, he was healthy, did not take any medications,
and smoked approximately 20 cigarettes daily. Blood 
morphology (including blood smear), urine analysis, and
other basic laboratory analyses were within the normal
range, except for elevated concentration of C reactive pro-
tein (40 mg/L). HIV infection/AIDS has been excluded.
Computed tomography (CT) revealed an irregular
but distinct extra-axial mass (6 × 3 cm), with a broad
base adjoining the frontal bone (Fig. 1). The main bulk
of the mass was on the right side but it crossed the mid-
line and infiltrated the falx. The mass compressed the
right frontal lobe and frontal horn and caused marked
peritumoral brain edema. It enhanced after contrast
injection, but no calcification was demonstrated. Based
on the CT image, the tumor was diagnosed as menin-
gioma and therefore further magnetic resonance imag-
ing (MRI) was deemed unnecessary to opt for a surgi-
cal resection.
The lesion was reached through a bifrontal cran-
iotomy and visually still resembled a meningioma with
its soft consistency, yellow-brown color, and somewhat
paler core. However, the consistency of the tumor was
much softer than in typical meningioma. The arachnoid
barrier was partly intact, and thus the lesion could be
easily separated from the adjacent cortex. There was also
a thin (~1 mm) layer of tumor tissue extending into the
epiarachnoid space along the brain surface up to 1-2 cm
beyond its main mass. The tumor invaded the anterior
third of the sagittal sinus and the adjacent dura mater
of the frontal region. All the masses were removed total-
ly with resection of the invaded segments of the dura,
sagittal sinus, and falx. There was an episodic epileptic
seizure in the postoperative phase; thereafter, the epilep-
sy could be successfully controlled pharmacologically.
The patient was discharged on the 7th day without neuro-
logical deficit. CT was performed 6 months and 7 years
after the surgery and MRI after 9 years (Fig. 2). No tu -
mor recurrence was demonstrated and the current year
is about to close a 10-year long follow up period in which
no signs of tumor recurrence have appeared.
The routine histopathological evaluation (HE) show -
ed a dispersed infiltration with numerous mononuclear
cells, composed mainly of lymphocytes and mature plas-
mocytes (Figs. 3A-B), as well as many small thin-walled
vessels in the brain parenchyma (Fig. 4A). Plasma cells
and lymphocytes surrounded all small vessels or infil-
trated adjacent brain tissue (Figs. 4B-D). Differential
diagnosis excluded plasmacytoma and B-cell lymphoma.
Mitotic activity (MIB-1 expression) was very low (about
2%). The picture was recognized as typical for a plasma
cell type of CD.
After a plasma cell type of CD had been confirmed,
the patient underwent further systemic examinations
with whole-body CT scanning to exclude multifocal
CD. Further laboratory examinations including tumor
markers and immunoglobulin concentrations were with-
Fig. 1. Computed tomography scan showing an extra-axial mass with a broad
base adjoining the frontal bone. The mass compresses the right frontal lobe
and the frontal horn and causes a marked peritumoral brain edema. It enhan-
ced after contrast injection but no calcifications were demonstrated
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in the normal range except for increased interleukin
(IL)-6 and IL-10 concentration.
Discussion
Based on the CT or MRI picture, this localized form
of CD belongs to the “tumor mimicking meningioma”
group of lesions. Of course, the mass is by no means
a kind of meningioma (in a case of plasma cell CD),
rather constituting a localized aggregate of lymph nodes.
Because the condition is so rare, preoperative differen-
tial diagnosis is very difficult, if at all possible. In pre-
viously described cases, the main feature of the CT was
a homogeneously enhancing extra-axial mass with no
calcifications and with a disproportionally marked per-
itumoral edema [6]. On MRI, the homogeneously en -
hancing mass was usually isointense in T1-weighted,
T2-weighted, and FLAIR images, while possibly being
hyperintense in diffusion-weighted imaging [6,9].
Sometimes, invasion into the sulcal space and dural
enhancement can also be demonstrated. The mass aris-
es from the dura matter or leptomeninges, the most com-
mon site of origin being located at the cerebral convex-
ity followed by the parafalcine dura matter [9]. Similar
radiological features were also found in our patient and,
as in all other published cases, the final diagnosis was
based on the histopathological evaluation and not on the
cerebral imaging.
According to the literature, 70% of patients with soli-
tary intracranial CD are women [4]. Also, there is a pre -
dilection to CD in patients suffering from HIV and
human herpes virus 8 infections [2]. From a diagnostic
point of view, it is worth noting that 50-90% of patients
with a plasma cell type CD demonstrate hematological
disorders such as anemia, leukocytosis, hypergamma-
globulinemia, and/or increased concentration of C-reac-
tive protein (CRP) [2]. Particularly, the increased serum
concentration of IL-6 is very important, and results in
increased IL-6 expression by plasma cells [8]. In the
present case, the concentrations of CRP, IL-6 and 
IL-10 were increased, but the examination was done
postoperatively, after histopathological diagnosis.
In all other reported studies, the etiological diagno-
sis was made postoperatively and the patients were treat-
Fig. 2. Magnetic resonance imaging scan showing no tumor recurrence 9 years
after surgery
Fig. 3. (A) CD3 expression (infiltration of T cells) within the lesion (× 100); (B) CD138 expression in plasma cells surrounding small vessels (× 40)
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ed surgically with no regrowth seen after total excision
[5-9]. Nevertheless, obtaining an exact preoperative
diagnosis could be of advantage because – in contrast
to meningioma – also conservative therapeutic options
can be considered in some patients with CD. Radio-
therapy, steroids and cytotoxic agents (cyclophos-
phamide, chlorambucil) have proven effective, especially
in the multicentric form of CD, which generally features
a worse prognosis [2,6].
In spite of the potentially effective conservative ap -
proach, in all reported case studies, surgical treatment was
attempted and reported to be effective. Nevertheless, 
the follow-up period in most reported cases was no longer
than 3 years and was usually between several months and
2 years [4]. Only Lacombe et al. [7] (who first reported
a case of solitary intracranial CD in 1983) followed their
patient up to 8 years; similarly, Cummings et al. [5] report-
ed a 5-year follow-up free of recurrence. Our 10-year fol-
low-up is the longest in the literature and may support 
the conclusion that operative treatment of solitary CD pro-
vides a valuable and permanent therapeutic effect [11].
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